Janek S Walker

8PUBLICATIONS
51CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma.

Janek S Walker, Kerstin Wenzl, Joseph P Novak

|Oct 09, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.

Melissa A Hopper, Abigail R Dropik, Janek S Walker

|Jan 07, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.

Zachary A Hing, Janek S Walker, Ethan C Whipp

|Sep 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions.

Pu Zhang, Lindsey T Brinton, Mehdi Gharghabi

|May 24, 2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.

Deborah M Stephens, Ying Huang, Amy S Ruppert

|Nov 04, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.

Janek S Walker, Zachary A Hing, Steven Sher

Pageof 2

Frequent Collaborators

3 joint publications

Matthew J Maurer

3 joint publications

Pearlly Yan

3 joint publications

Abigail R Dropik

3 joint publications

James S Blachly